SENSEX NIFTY

Glenmark Pharmaceuticals

Sep 26, 2016 at 09:13 | Source: CNBC-TV18
In an interview to CNBC-TV18, Prakash Diwan of Altamount Capital Management shared his readings and outlook on specific stocks and sectors.
Sep 23, 2016 at 10:28 | Source: CNBC-TV18
VK Sharma of HDFC Securities is of the view that one may buy Glenmark Pharma 940 Call and sell 960 Call.
Sep 20, 2016 at 16:00 | Source: CNBC-TV18
Vijay Chopra of enochventures.com feels that Glenmark Pharma may touch Rs 1100.
Sep 19, 2016 at 16:40 | Source: PTI
Glenmark Pharmaceuticals todaysaid it has entered into an agreement with US-based ParticleSciences Inc to develop and market a generic version ofCelgene's ABRAXANE which is used in treatments of breast andlung cancers.
Sep 19, 2016 at 15:49 | Source: Moneycontrol.com
Glenmark Pharmaceuticals, Inc., USA today announced that it has entered into a strategic development, license and commercialization agreement with Particle Sciences, Inc.to develop and market a generic version of Celgenes ABRAXANE product paclitaxel protein (albumin)-bound particles for injectable suspension.
Sep 19, 2016 at 11:30 | Source: CNBC-TV18
Amit Gupta of ICICIdirect is of the view that Glenmark Pharma should start performing with a traget of Rs 980.
Sep 14, 2016 at 14:02 | Source: PTI
"Glenmark Pharmaceuticals Inc USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Diclofenac Sodium gel, 3 per cent," the company said in a BSE filing.
Sep 14, 2016 at 10:10 | Source: Moneycontrol.com
The company's current portfolio consists of 110 products authorized for distribution in the US marketplace and 61 ANDAs pending approval with the USFDA.
Sep 14, 2016 at 08:33 | Source: Moneycontrol.com
Glenmark Pharmaceuticals Inc. USA has been granted final approval by the USFDA for Diclofenac Sodium Gel, 3 percent, the generic version of Solaraze Gel, 3 percent of Fougera Pharmaceuticals Inc.
Sep 14, 2016 at 08:01 | Source: CNBC-TV18
Tata Steel | Sun Pharma | Wipro | Cairn | Vedanta | Motherson Sumi | Claris Life | Reliance Capital | Reliance Defence | Mahindra CIE | Coal India | Amtek Auto | Godfrey Phillips | Alok Industries | Gitanjali Gems | Nalco | Setco Auto | NHPC | Sicagen India and Nandan Denim are stocks, which are in the news today.
Messages on Glenmark Pharmaceuticals »

Wire News

Platinum Member

631 Followers

News Now  

Glenmark Pharmaceuticals today said it has entered into an agreement with US-based Particle Sciences Inc to develop and market a generic version of Celgene's ABRAXANE which is used in treatments of breast and lung cancers.

4.40 PM Sep 19th

Wire News

Platinum Member

631 Followers

News Now  

Glenmark Pharmaceuticals has received final approval from the US health regulator for generic Diclofenac Sodium gel used for treatment of skin lesion.

2.02 PM Sep 14th

abhishek_sa
ilor02

New Member

1 Followers

Glenmark  

glenmark pharmaceuticals today announced receipt of final approval from us health regulator for its generic version of astrazeneca`s xylocaine ointment. the approval given by the us food

1.03 PM Sep 12th

Cool Cool

Platinum Member

4372 Followers

Glenmark  

Drug firm Glenmark Pharmaceuticals today said it is initiating investigational new drug-enabling studies for a novel antibody which has potential to kill cancer cells. The discovery and initiation of studies for the antibody, GBR 1372, is being done by the company’s wholly-owned subsidiary Glenmark

8.26 PM Sep 6th

Wire News

Platinum Member

631 Followers

News Now  

Drug firm Glenmark Pharmaceuticals today said it is initiating investigational new drug-enabling studies for a novel antibody which has potential to kill cancer cells.

5.52 PM Sep 6th

BSE/NSE Announcer

Platinum Member

17410 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated September 06, 2016 titled "Glenmark announces the Discovery and Initiation of IND-enabling studies of a novel Bispecific Monoclonal Antibody targeting EGFR".

2.40 PM Sep 6th

BSE/NSE Announcer

Platinum Member

17410 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 07, 2013, titled "Atovaquone Proguanil (Malarone) patent revoked & Glenmark launches first UK generic".

9.05 PM Feb 7th 2013

BSE/NSE Announcer

Platinum Member

17410 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated February 07, 2013 titled "Atovaquone Prognanil (Malarone®) patent revoked & Glenmark launches first UK generic".

6.32 PM Feb 7th 2013

Web Messenger

Platinum Member

367318 Followers

Glenmark  

Source:India Infoline - Glenmark Pharmaceuticals S.A. (GPSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India (GPL), announces the discovery and initiation of IND enabling studies of a novel clinical development candidate, GBR 830, an anti-OX40 monoclonal antibody. GBR 830 has

3.26 PM Feb 5th 2013

Web Messenger

Platinum Member

367318 Followers

Glenmark  

Source:The Hindu BusinessLine - New Delhi, Feb 4: Glenmark Pharmaceuticals today said it has initiated studies for the development of a new molecule ‘GBR 830’, which could possibly be used to treat diseases like Arthritis (RA) and bowel disease. In a statement, the Mumbai-headquartered firm said

3.09 PM Feb 5th 2013

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.